📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. (2021)

First Author: Richter AG

Attributed to: Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cei.13623

PubMed Identifier: 34082475

Publication URI: http://europepmc.org/abstract/MED/34082475

Type: Journal Article/Review

Volume: 205

Parent Publication: Clinical and experimental immunology

Issue: 2

ISSN: 0009-9104